Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics second quarter 2025 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Inc (DGX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Squarepoint Ops LLC Maxime Fortin (Cio) | 843,291 | $151,480,362 | +445% | 0.16% |
| 2. | 240,600 | $43,218,978 | -15% | 0.02% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 205,083 | $36,839,057 | -58% | 0.04% |
| 4. | 8 Knots Management Scott J. Green | 176,538 | $31,711,521 | +43% | 4.54% |
| 5. | Millennium Management Israel Englander | 155,196 | $27,877,857 | +916% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.51 | 4,000 | $222,023.20 | 44,222 | 2014-05-05 | Filing | |
| $50.71 | 2,600 | $131,846.00 | 5,658 | 2014-02-06 | Filing | |
| $50.70 | 2,400 | $121,680.00 | 3,058 | 2014-02-06 | Filing | |
| $59.34 | 5,000 | $296,676.50 | 68,034 | 2012-08-07 | Filing | |
| $56.89 | 20,000 | $1,137,748.00 | 63,034 | 2012-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $175.00 | 1,975 | $345,625.00 | 19,219 | 2025-08-06 | Filing | |
| $175.00 | 3,560 | $623,000.00 | 21,185 | 2025-08-06 | Filing | |
| $170.00 | 2,210 | $375,700.00 | 8,450 | 2025-07-31 | Filing | |
| $167.40 | 5,224 | $874,497.60 | 10,660 | 2025-07-30 | Filing | |
| $167.40 | 3,045 | $509,733.00 | 10,660 | 2025-07-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,233,576 | $2,556,777,257 | 0.04% | |
| 2. | 10,312,975 | $1,852,519,625 | 0.04% | |
| 3. | 5,184,999 | $931,381,370 | 0.03% | |
| 4. | 4,331,660 | $778,096,175 | 0.05% | |
| 5. | 3,039,848 | $545,318,462 | 0.61% |
News See All
Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center
Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts.
7 Most Undervalued Pot Stocks To Buy According To Analysts
The global cannabis market was worth $26.86 billion in 2022, Spherical Insights & Consulting data shows. Three years later, Mordor Intelligence valued the market at $44.60 billion.
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics First Quarter 2025 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (DGX): A Bull Case Theory
We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on DGX.
Top 8 AI News Updates Investors Shouldn’t Miss
On March 19th, the stock market bounced back after the US Federal Reserve kept interest rates unchanged at 4.25% to 4.5%. The Fed also anticipated two rate cuts this year despite elevated inflation.
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Fourth Quarter and Full-Year 2024 Conference Call. At the request of the company, this call is being recorded.
8 Most Undervalued Pot Stocks to Buy According to Analysts
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational purposes.
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Third Quarter 2024 conference call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Second Quarter 2024 conference call. At the request of the company, this call is being recorded.
Billionaire Hedge Funds
